Isaac Zentner
About Isaac Zentner
Isaac Zentner is the Director of MSAT and Process Development at Carisma Therapeutics, where he has worked since 2023. He holds a PhD in Molecular & Cell Biology & Genetics from Drexel University College of Medicine and has extensive experience in process development across various institutions.
Current Role at Carisma Therapeutics
Isaac Zentner serves as the Director of MSAT and Process Development at Carisma Therapeutics. He has held this position since 2023, contributing to the company's efforts in advancing cell therapy technologies. His role involves overseeing the manufacturing science and technology processes, ensuring that development aligns with regulatory standards and industry best practices.
Previous Experience at Carisma Therapeutics
Prior to his current role, Isaac Zentner worked at Carisma Therapeutics in various capacities. He served as Associate Director of Process Development from 2022 to 2023 and as Senior Manager of Process Development for three months in 2022. His experience at Carisma involved significant contributions to the development and optimization of processes related to cell therapies.
Education and Expertise
Isaac Zentner holds a Doctor of Philosophy (PhD) in Molecular & Cell Biology & Genetics from Drexel University College of Medicine. He also earned a Bachelor of Science (B.S.) in Biochemistry and Molecular Biology from Dickinson College. His educational background provides a solid foundation for his work in biopharmaceutical development and process optimization.
Research Experience at Drexel University College of Medicine
Isaac Zentner worked at Drexel University College of Medicine from 2006 to 2010 as a Research Specialist. During this time, he gained valuable experience in research methodologies and laboratory techniques. He continued his academic journey at Drexel as a PhD candidate from 2010 to 2016, further enhancing his expertise in molecular and cell biology.
Postdoctoral Fellowship at Rutgers University
Isaac Zentner completed a postdoctoral fellowship at Rutgers University from 2016 to 2019. This role allowed him to deepen his research skills and contribute to scientific knowledge in his field. His time at Rutgers was marked by a focus on advanced research projects that aligned with his academic background.